ARGENX SE is 2.4x more valuable than BioNTech SE by market capitalization ($53.35 B vs $21.79 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ARGX | BNTX |
|---|---|---|
| Market cap | $53.35 B | $21.79 B |
| US-listed rank | #306 | #587 |
| SEC filings | 272 | 548 |
ARGENX SE is 2.4x more valuable than BioNTech SE by market capitalization ($53.35 B vs $21.79 B).
Full pages: ARGENX SE and BioNTech SE, or browse the full rankings.